Table 2.
Definitions of American Joint Committee on Cancer and European Neuroendocrine Tumor Society staging for pancreatic neuroendocrine tumors
| AJCC 7th staging classification | AJCC 8th and ENETS staging classification | ||
| T1 | Limited to the pancreas, ≤ 2 cm in greatest dimension | T1 | Tumor limited to the pancreas, ≤ 2 cm |
| T2 | Limited to the pancreas, > 2 cm in greatest dimension | T2 | Tumor limited to the pancreas, 2-4 cm |
| T3 | Beyond the pancreas but without involvement of the superior mesenteric artery | T3 | Tumor limited to the pancreas, > 4 cm, or invading the duodenum or common bile duct |
| T4 | Involvement of the celiac axis or superior mesenteric artery (unresectable tumor) | T4 | Tumor invades adjacent structures |
| N0 | No regional lymph node metastasis | N0 | No regional lymph node metastasis |
| N1 | Regional lymph node metastasis | N1 | Regional lymph node metastasis |
| M0 | No distant metastasis | M0 | No distant metastasis |
| M1 | Distant metastasis | M1 | Distant metastasis |
| M1a | Metastasis confined to liver | ||
| M1b | Metastasis in at least one extrahepatic site | ||
| M1c | Both hepatic and extrahepatic metastases |
AJCC: American Joint Committee on Cancer; ENETS: European Neuroendocrine Tumor Society.